Long-term Safety and Efficacy of Delatestryl in Treating Hypogonadism in American Males
Reading Time: 2 minutes Introduction Hypogonadism, a condition characterized by the body's inability to produce sufficient testosterone, affects a significant number of American males. The management of this condition often involves testosterone replacement therapy (TRT), with Delatestryl being a commonly prescribed injectable form. This article delves into the extensive clinical data regarding the long-term safety and tolerability of Delatestryl, administered by Endo Pharmaceuticals, in treating hypogonadism among American males. Overview of Delatestryl and Hypogonadism Delatestryl, a brand name for testosterone enanthate, is an injectable form of testosterone used to treat hypogonadism. Hypogonadism can lead to a variety of symptoms including decreased libido, fatigue, and...


